Who owns Nephros Inc?
- Ticker: NEPH
- CUSIP Number: 640671400
Tip: Access positions for across all investors
Analyze quarterly positions in Nephros with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Nephros stock
Who bought or sold Nephros Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Wexford Capital | 3.6M | $11M | 0% | Mar 2026 |
|
| Vanguard Capital Management | 199k | $592k | 100% | Mar 2026 |
|
| Petersen, Flynn & Dinsmore | 129k | $384k | 100% | Mar 2026 |
|
| Bard Associates | 121k | $361k | 0% | Mar 2026 |
|
| Mesirow Financial Investment Management International Equity | 120k | $358k | 140% | Mar 2026 |
|
| Morgan Stanley | 111k | $331k | 518% | Mar 2026 |
|
| Renaissance Technologies | 99k | $296k | -4% | Mar 2026 |
|
| Geode Capital Management | 73k | $217k | -2% | Mar 2026 |
|
| HighTower Advisors | 60k | $178k | 0% | Mar 2026 |
|
| Essex Investment Management | 39k | $116k | 0% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 37k | $110k | 100% | Mar 2026 |
|
| William Blair $ Company | 36k | $108k | 0% | Mar 2026 |
|
| De Lisle Partners | 25k | $75k | 0% | Mar 2026 |
|
| Citadel Advisors | 21k | $62k | 1% | Mar 2026 |
|
| Dimensional Fund Advisors | 21k | $62k | 53% | Mar 2026 |
|
| Navellier & Associates | 19k | $57k | -30% | Mar 2026 |
|
| State Street Corporation | 16k | $47k | 0% | Mar 2026 |
|
| Goldman Sachs Group | 14k | $42k | -25% | Mar 2026 |
|
| Springbok Capital Management | 14k | $41k | -10% | Mar 2026 |
|
| Elkhorn Partners Limited Partnership | 12k | $36k | 71% | Mar 2026 |
|
| Spears Abacus Advisors | 11k | $33k | 0% | Mar 2026 |
|
| Northern Trust | 11k | $32k | 0% | Mar 2026 |
|
| Royal Bank of Canada | 747.00 | $2.0k | 100% | Mar 2026 |
|
| Advisor Group Holdings | 175.00 | $520.992500 | -89% | Mar 2026 |
|
| Harbour Investments | 50.00 | $149.000000 | 0% | Mar 2026 |
|
| Jones Financial Companies, L.L | 31.00 | $89.999200 | 0% | Mar 2026 |
|
Who sold out of Nephros?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cambridge Investment Research Advisors | Dec 2025 | 69k | $337k |
| Quadrature Capital | Dec 2025 | 23k | $112k |
| Marshall Wace | Dec 2025 | 22k | $107k |
| XTX Topco | Dec 2025 | 22k | $106k |
| Heron Bay Capital Management | Dec 2025 | 14k | $66k |
| Centiva Capital | Dec 2025 | 11k | $53k |
| Kestra Advisory Services | Dec 2025 | 6.0k | $29k |